No Picture
Biotech
Positive and clinically meaningful pivotal clinical results announced in 2022 in both metastatic and locally advanced indications WALTHAM, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and more...